AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.740
-0.060 (-1.25%)
At close: Apr 28, 2026, 4:00 PM EDT
4.740
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $170.62 million as of April 28, 2026. Its market cap has increased by 368.48% in one year.
Market Cap
170.62M
Enterprise Value
117.12M
1-Year Change
368.48%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $170.62M, a decrease of -39.30%. That is a compound annual growth rate of -11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 172.78M | 453.10% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 186.84M |
| Cartesian Therapeutics | 182.91M |
| Precision BioSciences | 182.30M |
| Acumen Pharmaceuticals | 181.98M |
| Tonix Pharmaceuticals Holding | 181.26M |
| Unicycive Therapeutics | 180.20M |
| Corbus Pharmaceuticals Holdings | 179.23M |
| Humacyte | 177.03M |